Technology News and Research

RSS

New technology opens up pathways for disease cures

The understanding of diseases such as Parkinson's and Alzheimer's is set to take a step forward following groundbreaking technology at which will enable cell analysis using automated 3D microscopy.

17 Feb 2012

FDA approves Medtronic's Resolute Integrity DES to treat CAD

Advancing the clinical practice of interventional cardiovascular medicine, Medtronic, Inc. (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) approval of the Resolute Integrity Drug-Eluting Stent (DES) for the treatment of coronary artery disease.

From Medtronic 17 Feb 2012

Greatbatch acquires NeuroNexus

Greatbatch, Inc., today announced the acquisition of NeuroNexus Technologies for approximately $12 million in cash, including the assumption of debt and future considerations.

17 Feb 2012

Digital games become an important tool for self-management of illness and chronic conditions

Millions of dollars and immeasurable hours of research and development are being invested to develop and employ increasingly sophisticated hardware and software technologies to deliver innovative new personalized health care interventions.

17 Feb 2012

CPALMS educator platform to expand with $10.5M grant

Between teaching, paperwork, assessments, discipline and grading, schoolteachers have a demanding job, and lately it's becoming even tougher.

17 Feb 2012

ESF-COST launch Responses to Environmental and Societal Challenges for our Unstable Earth initiative

Resolving the world's major challenges whether climate change, environmental pollution, urbanisation, our ageing population or resource scarcity requires a sweeping shift in our approach to sustainability research and education, a group of leading scientists told European policy makers today during the launch of their report "Responses to Environmental and Societal Challenges for our Unstable Earth" (RESCUE).

17 Feb 2012

UK's leading model agencies back 'No Sunbed' campaign

Ahead of London Fashion Week, leading model agencies sign groundbreaking 'No Sunbed' policy agreement as part of Cancer Research UK's R UV UGLY? campaign after warnings on health and appearance

17 Feb 2012

New process can transform discarded human fat into soft-tissue substitute

A new process for transforming discarded human fat into a soft-tissue substitute for use in reconstructive surgery is laying the groundwork for creating an Ontario-based regenerative medicine initiative focused on developing products for reconstructive and cosmetic surgery.

17 Feb 2012

Study: 3D organization of chromosomes plays a role in cancer genomics

It is well understood that chromosomal translocation - a process whereby pieces of two chromosomes break off and exchange places - is a hallmark of many cancers including leukemia, thyroid cancer and lymphoma and play an important part in how healthy cells become cancerous. The role spatial proximity plays in why certain chromosomal translocations happen repeatedly, however, has been a long-standing area of debate among scientists.

17 Feb 2012

Brandeis professor investigates wallpaper-like liner technology for tackling malaria

Can an innovative wallpaper-like liner help reduce the number of cases of malaria, and if so, will it be cost effective? Donald S. Shepard, a professor at the Schneider Institutes for Health Policy at the Heller School wants to know. And he has gotten the Bill and Melinda Gates Foundation to help. A grant, totaling nearly $500,000 over the next three years, will allow Shepard and collaborators to pursue their research in Kenya and Tanzania.

17 Feb 2012

Augmented toys may help children with autism

Making play sets more interactive and giving children with autism greater opportunities to control and add content of their own to the game could improve cooperative play with other children as well as giving them greater confidence in understanding how objects interact.

17 Feb 2012

Synthetic Oct4 protein more effective at turning genes into pluripotent stem cells

Scientists have found a way to generate and maintain stem cells much more efficiently by amplifying the effect of an essential protein.

17 Feb 2012

UC San Diego offers catheter ablation for patients with atrial fibrillation

UC San Diego Sulpizio Cardiovascular Center is now offering patients with atrial fibrillation the breakthrough benefits of heat energy, or radio frequency waves, to irreversibly alter heart tissue that triggers an abnormal heart rhythm or arrhythmia.

17 Feb 2012

Scientist uses GPUs to simulate inner workings of human cells

The cure for cancer comes down to this: video games. In a research lab at Wake Forest University, biophysicist and computer scientist Samuel Cho uses graphics processing units (GPUs), the technology that makes videogame images so realistic, to simulate the inner workings of human cells.

17 Feb 2012

Cryoablation increases survival rates in ovarian cancer patients

Ovarian cancer, which killed 15,000 American women last year, is one of the deadliest forms of cancer. A team of Wayne State University School of Medicine researchers recently proved that freezing tumors increases survival rates in ovarian cancer patients.

17 Feb 2012

FDA grants orphan drug designation to CSL Behring's rVIIa-FP

CSL Behring announced today that the company has been granted orphan drug designation by the U.S. Food and Drug Administration (FDA) for its novel recombinant fusion protein linking coagulation factor VIIa with albumin.

16 Feb 2012

HeartWare revenues for fiscal 2011 increase to $82.8 million

HeartWare International, Inc., a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, announced revenue of $23.1 million for the fourth quarter ended December 31, 2011, as compared to $20.9 million for the fourth quarter of 2010.

16 Feb 2012

NCQA tool doesn't adequately evaluate quality of diabetes care at health centers

On the health front, the poor often have at least two things going against them: a lack of insurance and chronic illnesses, of which diabetes is among the most common.

16 Feb 2012

Illumina introduces Cancer Analysis Service from IGN

Illumina, Inc. today announced the launch of a Cancer Analysis Service from the Illumina Genome Network (IGN) that leverages the high accuracy of Illumina technologies to provide cancer researchers with easily interpretable tumor/normal sequencing data to quickly move their research forward.

From Illumina, Inc. 16 Feb 2012

Foreign-born scientists to receive Vilcek Prize in Biomedical Science

The Vilcek Foundation is pleased to announce the winners of its annual Vilcek Prizes in Biomedical Science, honoring the contributions of foreign-born scientists.

16 Feb 2012